Loading...
•
Dec 31, 2025
Cronos Q4 2025 Earnings Report
Estimated Revenue:$49M
+1.4% YoY
Estimated EPS:$0.02
+303.0% YoY
Key Takeaways
Cronos achieved record Q4 2025 net revenue of 44531000, up 47% year-over-year, driven by higher cannabis flower sales in Israel and other countries and stronger Canadian extract sales. Gross profit increased 50% to 16189000, and Adjusted EBITDA turned positive at 456000. The company reported a net loss of 491000 in the quarter.
Net revenue increased 47% year-over-year to 44531000, a quarterly record.
Gross profit rose 50% to 16189000, with gross margin steady at 36%.
Adjusted EBITDA improved to 456000 from a loss in the prior year period.
Cash and cash equivalents totaled 791794000 at quarter end.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Cronos expressed confidence entering 2026, highlighting expected benefits from the CanAdelaar acquisition, Cronos GrowCo expansion, and continued international growth to support sustainable net revenue and Adjusted EBITDA growth.
Positive Outlook
- Pending acquisition of CanAdelaar expected to establish a strategic European footprint.
- Expansion of Cronos GrowCo expected to provide scale benefits.
- Continued strength of international markets including Israel.
- Focus on proprietary product growth and brand leadership.
- Strong balance sheet with significant cash reserves.
Challenges Ahead
- Transaction subject to regulatory approvals in the Netherlands.
- Exposure to foreign currency transaction volatility.
- Ongoing regulatory risks including anti-dumping investigation in Israel.
- Competitive pressures in Canadian cannabis market.
Loading...
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...